Multicentric Bowen disease in linear porokeratosis

European Journal of Dermatology

Volumn 17, Issue 5, 2007, Pages 439-440

  Guenova, Emmanuella ^a   Hoetzenecker, Wolfram ^a   Metzler, Gisela ^a   Röcken, Martin ^a   Schaller, Martin ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Bowen disease; Linear porokeratosis; Malignant degeneration

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; BOWENOID PAPULOSIS; CASE REPORT; CELL PROLIFERATION; CLINICAL FEATURE; HISTOPATHOLOGY; HUMAN; KERATINOCYTE; MALE; POROKERATOSIS; PUNCH BIOPSY; SKIN SURGERY; SQUAMOUS CELL CARCINOMA;

BOWEN'S DISEASE; HUMANS; MALE; MIDDLE AGED; POROKERATOSIS; SKIN; SKIN NEOPLASMS;

EID: 34548763812     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: 10.1684/ejd.2007.0244     Document Type: Article

References (18)

1. Wade TR, Ackerman AB. Cornoid lamellation. A histologic reaction pattern. Am J Dermatopathol 1980; 2: 5-15.
2. Chernosky ME, Freeman RG. Disseminated superficial actinic porokeratosis (DSAP). Arch Dermatol 1967; 96: 611-24.
3. Guss SB, Osbourn RA, Lutzner MA. Porokeratosis plantaris, palmaris, et disseminata. A third type of porokeratosis. Arch Dermatol 1971; 104: 366-73.
4. Guss SB. Porokeratosis. Arch Dermatol 1972; 105: 297.
5. Otsuka F, Someya T, Ishibashi Y. Porokeratosis and malignant skin tumors. J Cancer Res Clin Oncol 1991; 117: 55-60.
6. Sasson M, Krain AD. Porokeratosis and cutaneous malignancy. A review. Dermatol Surg 1996; 22: 339-42.
7. Otsuka F, Iwata M, Watanabe R, Chi HI, Ishibashi Y. Porokeratosis: clinical and cellular characterization of its cancer-prone nature. J Dermatol 1992; 19: 702-6.
8. Happle R. Cancer proneness of linear porokeratosis may be explained by allelic loss. Dermatology 1997; 195: 20-5.
9. Boente MC, Lopez-Baro AM, Frontini M. V, Asial RA. Linear porokeratosis associated with disseminated superficial actinic porokeratosis: a new example of type II segmental involvement. Pediatr Dermatol 2003; 20: 514-8.
10. Freyschmidt-Paul P, Hoffmann R, Konig A, Happle R. Linear porokeratosis superimposed on disseminated superficial actinic porokeratosis: report of two cases exemplifying the concept of type 2 segmental manifestation of autosomal dominant skin disorders. J Am Acad Dermatol 1999; 41: 644-7.
11. Lucker GP, Steijlen PM. The coexistence of linear and giant porokeratosis associated with Bowen's disease. Dermatology 1994; 189: 78-80.
12. Commens CA, Shumack SP. Linear porokeratosis in two families with disseminated superficial actinic porokeratosis. Pediatr Dermatol 1987; 4: 209-14.
13. Welton WA. Linear porokeratosis in a family with DSAP. Arch Dermatol 1972; 106: 263.
14. Happle R. Loss of heterozygosity in human skin. J Am Acad Dermatol 1999; 41: 143-64.
15. Nelson C, Cowper S, Morgan M. p53, mdm-2, and p21 waf-1 in the porokeratoses. Am J Dermatopathol 1999; 21: 420-5.
16. Magee JW, McCalmont TH, LeBoit PE. Overexpression of p53 tumor suppressor protein in porokeratosis. Arch Dermatol 1994; 130: 187-90.
17. Jensen JM, Egberts F, Proksch E, Hauschild A. Disseminated porokeratosis palmaris and plantaris treated with imiquimod cream to prevent malignancy. Acta Derm Venereol 2005; 85: 550-1.
18. Goldman GD, Milstone LM. Generalized linear porokeratosis treated with etretinate. Arch Dermatol 1995; 131: 496-7.